No abstract available
Keywords:
epigenetic changes; hepatocellular carcinoma; hepatocyte growth factor; mesenchymal–epithelial transition; tumor suppressor gene; tyrosine kinase inhibitors.
MeSH terms
-
Animals
-
Antineoplastic Agents / pharmacology
-
Crizotinib / pharmacology
-
Hepatocyte Growth Factor / antagonists & inhibitors
-
Hepatocyte Growth Factor / genetics
-
Hepatocyte Growth Factor / metabolism*
-
Humans
-
Liver Neoplasms / drug therapy
-
Liver Neoplasms / metabolism*
-
Liver Neoplasms / pathology
-
Proto-Oncogene Proteins c-met / antagonists & inhibitors
-
Proto-Oncogene Proteins c-met / genetics
-
Proto-Oncogene Proteins c-met / metabolism*
Substances
-
Antineoplastic Agents
-
Crizotinib
-
Hepatocyte Growth Factor
-
Proto-Oncogene Proteins c-met